Dr.med. Lukas HUBER Direktor, Biozentrum und Leiter, Division für Zellbiologie, Medizinische Universität Innsbruck; Chief Scientific Officer, ONCOTYROL - Center for Personalized Cancer Medicine GmbH, Innsbruck
CV
1990-1993 | Postdoc at the European Molecular Biology Laboratory (EMBL), Cell Biology Program, Heidelberg, Prof. Dr. Kai Simons |
1993-1995 | Maître Assistant, Département de Biochimie, Université de Géneve, Sciences II, Genève, Switzerland, Prof. Dr. Jean Gruenberg |
1996-2002 | Group Leader, IMP, Institute of Molecular Pathology, Vienna, Austria |
2002-2004 | Full Professor, Director and Head of the Biocenter, Medical University Innsbruck and Director Division of Cell Biology |
since 2005 | Director and Head of the Biocenter, Medical University Innsbruck and Director Division of Cell Biology |
2007-2008 | Co-Director of the Integrated Research and Therapy Center (IFTZ), Innsbruck |
since 2009 | CSO, Center for Personalized Medicine, ONCOTYROL, Innsbruck |
since 2010 | Austrian representative and Steering Committee member to the ESF Research Networking Program on "Frontiers in Functional Genomics" (FFG) |
Mitgliedschaften
Senior Editor Proteomics, FEBS Letters; Associate Editor Electrophoresis, Current and Molecular Life Sciences, Current Opinion in Molecular Therapeutics, Histochemistry and Cell Biology, Current Analytical Chemistry, Current Signal Transduction Therapy | |
Coordinator of SFB021 "Cell Proliferation and Cell Death in Tumors", Austrian Proteomics Platform (GEN-AU), GROWTHSTOP (EU, FP6, LSHC-CT-2006-037731) |
Publikationen
154 publications, >5500 citations, average citation per item=36, h-factor=43 (ISI Web of Science®) |
Auszeichnungen
Hoechst Price, 1990 | |
Johnson&Johnson Research Grant Award, 1995 | |
Research Price in Cell Biology, DGZ, German Society for Cell Biology, 1995 |